DeviceMed

Anschluss an Organarterien: FDA erweitert VBX-Indikation

(Bild: Redaktion Devicemed; KI-generiertes Symbolbild) Die FDA hat die Zweckbestimmung des ballonexpandierbaren ...
Cardiovascular Business

FDA approves aortic stent graft from Gore for FEVAR and BEVAR

FEVAR and BEVAR transformed how complex aortic aneurysms are treated. Clinicians now have an FDA-approved bridging stent option specifically indicated for these procedures.
Medical Product Outsourcing

Gore Wins FDA Approval for VBX Stent Graft in FEVAR, BEVAR

The expanded indication covers the device’s use as a bridging stent in fenestrated and branched aortic repair.
TCTMD

Viabahn VBX Stent Graft Gains FDA-Approved Indications in Complex Aortic Disease

The balloon-expandable device can now be used as a bridge in fenestrated and branched endovascular aortic repair.
Endovascular Today

Gore Viabahn VBX Stent Graft Gains FDA Approval for Use in FEVAR and BEVAR

Gore & Associates announced FDA approval of an expanded indication for the company’s Viabahn VBX balloon expandable e ...

FDA APPROVES GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS FOR EXPANDED USE IN FEVAR AND BEVAR

W. L. Gore & Associates' medical business (Gore) today announced U.S. Food and Drug Administration approval of an expanded indication for the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX ...
Vascular News

US FDA approves Gore Viabahn VBX balloon-expandable endoprosthesis for expanded use in FEVAR and BEVAR

Gore today announced US Food and Drug Administration (FDA) approval of an expanded indication for the company's Viabahn VBX ...